Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/30/2025

Criteria for ICD Removal

Infectious Indications

  • The American Heart Association recommends complete device and lead removal for patients with definite ICD infection, including valvular/lead endocarditis or sepsis, pocket infection, valvular endocarditis without definite lead involvement, or occult staphylococcal bacteremia 1, 2, 3
  • Complete removal is required for patients with pocket infection, including abscess formation, device erosion, skin adherence, chronic draining sinus, or purulent drainage from the pocket 1, 2, 3
  • The American College of Cardiology recommends removal for patients with occult staphylococcal bacteremia without other identified source 1, 2, 3
  • Removal is also recommended for patients with relapsing or persistent Gram-negative bacteremia despite appropriate antibiotics with no other defined focus 1, 6
  • Valvular endocarditis, even without definite lead involvement, is an indication for removal 1, 2, 3

Non-Infectious Indications

  • The American Heart Association recommends ICD shock therapy deactivation, not removal, for patients with refractory heart failure symptoms, refractory sustained ventricular arrhythmias, or terminal illness from other causes 7
  • Patients should be informed at implantation and during advance care planning that shock therapy can be deactivated at any time 7

Post-Removal Management

  • The American Heart Association recommends antimicrobial therapy for 10-14 days after device removal for pocket infection only 1, 6, 2
  • For bloodstream infection, antimicrobial therapy should be continued for at least 14 days after device removal 1, 6, 2
  • Complicated infections, such as endocarditis or septic thrombophlebitis, require antimicrobial therapy for 4-6 weeks 1, 6, 2
  • Before reimplanting, assess whether the patient still requires device therapy, as one-third to one-half of patients may not need reimplantation due to resolved indications 6, 2, 3
  • Repeat blood cultures must be negative for at least 72 hours before new device placement, and for valvular infection, reimplantation should be delayed for at least 14 days after first negative blood culture 1, 9
  • Reimplantation on the contralateral side is recommended whenever possible to avoid relapsing infection 9, 6, 3

Bridging Strategy

  • A wearable cardioverter-defibrillator is reasonable for patients with history of sudden cardiac arrest or sustained ventricular arrhythmia requiring temporary ICD removal due to infection (Class IIa) 7, 8
  • Active-fixation leads connected to external pacing generators can serve as a bridge until reimplantation 2, 3